Last reviewed · How we verify
Polyamide
Polyamide is a Small molecule drug developed by Universidad Científica del Sur. It is currently in Phase 1 development. Also known as: Nylon.
-
Baseline phase 1 → approval rate
+9.6pp
Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2033–2036 | — |
| EMA | EU | 2034–2037 | +0.7 yr |
| MHRA | GB | 2034–2037 | +0.7 yr |
| Health Canada | CA | 2034–2038 | +0.9 yr |
| TGA | AU | 2034–2038 | +1.2 yr |
| PMDA | JP | 2034–2038 | +1.5 yr |
| NMPA | CN | 2035–2039 | +2.3 yr |
| MFDS | KR | 2034–2038 | +1.4 yr |
| CDSCO | IN | 2034–2039 | +1.8 yr |
| ANVISA | BR | 2035–2039 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Polyamide |
|---|---|
| Also known as | Nylon |
| Sponsor | Universidad Científica del Sur |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States (NA)
- The Effect of Collagen Scaffold Augmentation in Achilles Tendon Rupture Repair (NA)
- Antibiotic-coated Braided Suture Study (NA)
- Suture Repair of Lacerations in the ED: Comparison Between Two Suture Materials (NA)
- Ecofriendly Versus Nylon Tooth Brushes on Cariogram Outcomes (NA)
- Conventional Non-Penetrating Deep Sclerectomy Versus Modified Subflap Mattress Suture in OAG (NA)
- Cosmetic Results With Tissue Adhesive vs. Subdermal Sutures in Cesarean Section (NA)
- Using Lymphovenous Bypass to Alleviate Diabetic Peripheral Neuropathy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Polyamide CI brief — competitive landscape report
- Polyamide updates RSS · CI watch RSS
- Universidad Científica del Sur portfolio CI
Frequently asked questions about Polyamide
What is Polyamide?
Who makes Polyamide?
Is Polyamide also known as anything else?
What development phase is Polyamide in?
Related
- Manufacturer: Universidad Científica del Sur — full pipeline
- Therapeutic area: All drugs in Other
- Also known as: Nylon
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing